EDESA BIOTECH, INC.: 10-Q filed 2015-05-11
What EDESA BIOTECH, INC. reported in its quarterly report filed 2015-05-11 (fiscal Q2 2015): 29 published measures, 92 facts as tagged in accession 0001144204-15-029347.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-05-11
- Fiscal period
- fiscal Q2 2015
- Accession
- 0001144204-15-029347 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All EDESA BIOTECH, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 11,826,615 | USD | |
| At 2014-09-30 | 14,827,715 | USD | |
| At 2014-08-31 | 14,473,962 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 2,903,875 | USD | |
| At 2014-09-30 | 4,362,980 | USD | |
| At 2014-08-31 | 6,773,329 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 8,922,740 | USD | |
| At 2014-09-30 | 10,464,735 | USD | |
| At 2014-08-31 | 7,700,633 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 11,145,555 | USD | |
| At 2014-09-30 | 13,769,953 | USD | |
| At 2014-08-31 | 13,427,404 | USD | |
| At 2014-03-31 | 15,424,645 | USD | |
| At 2013-09-30 | 15,478,038 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | -426,164 | USD | 90 |
| 2014-10-01 to 2015-03-31 | -1,769,641 | USD | 182 |
| 2014-01-01 to 2014-03-31 | -1,433,854 | USD | 90 |
| 2013-10-01 to 2014-03-31 | -7,011,044 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-03-31 | 57,694 | USD | 182 |
| 2013-10-01 to 2014-03-31 | 250,666 | USD | 182 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | 187,627 | USD | 90 |
| 2014-10-01 to 2015-03-31 | 400,288 | USD | 182 |
| 2014-01-01 to 2014-03-31 | 114,371 | USD | 90 |
| 2013-10-01 to 2014-03-31 | 173,196 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | -34,261,927 | USD | |
| At 2014-09-30 | -32,492,286 | USD | |
| At 2014-08-31 | -33,620,190 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | 79,546,650 | shares | 90 |
| 2014-10-01 to 2015-03-31 | 79,503,361 | shares | 182 |
| 2014-01-01 to 2014-03-31 | 76,237,455 | shares | 90 |
| 2013-10-01 to 2014-03-31 | 76,299,105 | shares | 182 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | 79,546,650 | shares | 90 |
| 2014-10-01 to 2015-03-31 | 79,503,361 | shares | 182 |
| 2014-01-01 to 2014-03-31 | 76,237,455 | shares | 90 |
| 2013-10-01 to 2014-03-31 | 76,299,105 | shares | 182 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | -0.01 | USD/shares | 90 |
| 2014-10-01 to 2015-03-31 | -0.02 | USD/shares | 182 |
| 2014-01-01 to 2014-03-31 | -0.02 | USD/shares | 90 |
| 2013-10-01 to 2014-03-31 | -0.09 | USD/shares | 182 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | -0.01 | USD/shares | 90 |
| 2014-10-01 to 2015-03-31 | -0.02 | USD/shares | 182 |
| 2014-01-01 to 2014-03-31 | -0.02 | USD/shares | 90 |
| 2013-10-01 to 2014-03-31 | -0.09 | USD/shares | 182 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | 9,000 | USD | 90 |
| 2014-10-01 to 2015-03-31 | 18,800 | USD | 182 |
| 2014-01-01 to 2014-03-31 | 11,400 | USD | 90 |
| 2013-10-01 to 2014-03-31 | 12,200 | USD | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 368,432 | USD | |
| At 2014-09-30 | 388,340 | USD | |
| At 2014-08-31 | 387,392 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-03-31 | 198,927 | USD | 182 |
| 2013-10-01 to 2014-03-31 | 614,312 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 11,442,283 | USD | |
| At 2014-09-30 | 14,423,475 | USD | |
| At 2014-08-31 | 14,070,670 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 2,903,875 | USD | |
| At 2014-09-30 | 672,174 | USD | |
| At 2014-08-31 | 1,420,666 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | 1,377,261 | USD | 90 |
| 2014-10-01 to 2015-03-31 | 2,915,336 | USD | 182 |
| 2014-01-01 to 2014-03-31 | 1,555,006 | USD | 90 |
| 2013-10-01 to 2014-03-31 | 3,309,438 | USD | 182 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 135,151 | USD | |
| At 2014-09-30 | 34,891 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | 281,584 | USD | 90 |
| 2014-10-01 to 2015-03-31 | 700,405 | USD | 182 |
| 2014-01-01 to 2014-03-31 | 733,096 | USD | 90 |
| 2013-10-01 to 2014-03-31 | 1,281,321 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 79,546,650 | shares | |
| At 2014-09-30 | 79,419,850 | shares | |
| At 2014-08-31 | 78,268,850 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 963,586 | USD | |
| At 2014-09-30 | 906,603 | USD | |
| At 2014-08-31 | 893,126 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 595,154 | USD | |
| At 2014-09-30 | 518,263 | USD | |
| At 2014-08-31 | 505,734 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | 785,681 | USD | 90 |
| 2014-10-01 to 2015-03-31 | 1,727,834 | USD | 182 |
| 2014-01-01 to 2014-03-31 | 646,670 | USD | 90 |
| 2013-10-01 to 2014-03-31 | 1,667,800 | USD | 182 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-03-31 | 77,602 | USD | 182 |
| 2013-10-01 to 2014-03-31 | 79,057 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | 772,470 | USD | 90 |
| 2014-10-01 to 2015-03-31 | 764,207 | USD | 182 |
| 2014-01-01 to 2014-03-31 | 18,181 | USD | 90 |
| 2013-10-01 to 2014-03-31 | -3,862,602 | USD | 182 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-03-31 | 18,800 | USD | 182 |
| 2013-10-01 to 2014-03-31 | 12,200 | USD | 182 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-03-31 | -26,867 | USD | 182 |
| 2013-10-01 to 2014-03-31 | -87,643 | USD | 182 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-03-31 | 100,260 | USD | 182 |
Inspect the source
- Entity
- EDESA BIOTECH, INC. / CIK 0001540159
- Captured
- 2026-09-20T09:17:32.413Z
- SEC response SHA-256
0f44de1ccf1eff46a1af17dc21d4a3bb38216bbf46e813f5a136d29e08bfd65d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001540159.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))